6505--Teriparatide Injection (VA-26-00049896)

The VA National Acquisition Center is seeking proposals for an unrestrictive procurement of Teriparatide Injection (RFP 36E79726R0020) to supply the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The formal Request for Proposal will be issued in commercial item format in accordance with FAR Part 12 on or about May 1, 2026, with a closing date of May 19, 2026 at 2:30 PM Central Time. Offerors must demonstrate the ability to provide an uninterrupted source of supply and submit the exact drug name as it appears on the label along with a unique NDC number. The solicitation will be available exclusively through SAM.gov, and all responsible sources are eligible to submit offers, with the VA planning to award one contract to the responsible offeror who best meets the requirements. Questions should be directed to Billy Fong, the Contract Specialist, at billy.fong@va.gov or 708-786-4992, and interested parties are advised to continuously monitor SAM.gov for any amendments or changes to the solicitation.

This procurement carries no set-aside designation and has an estimated annual requirement of 39,038 pens of Teriparatide 250MCG/ML (560MCG) injection in 2.24ML pen format. The contract will span one base year plus four pre-priced one-year option periods, providing a potential five-year supply agreement for the federal agencies involved. Contract items will be distributed through the VA's and DOD's respective Pharmaceutical Prime Vendor Programs to ensure efficient delivery across multiple federal entities. The NAICS code is 325412 (Pharmaceutical Preparation Manufacturing), and the Product Service Code is 6505 (Drugs and Biologicals). No specific award value or budget range has been disclosed in the pre-solicitation notice, and no incumbent contractor information has been provided at this stage.